Cytokines and endotoxin removal by sorbents and its application in push-pull sorbent-based pheresis: The biologic-DTPF system

被引:25
作者
Steczko, J
Ash, SR
Blake, DE
Carr, DJ
Bosley, RH
机构
[1] HemoCleanse Inc, W Lafayette, IN 47906 USA
[2] Purdue Univ, Dept Vet Clin Sci, W Lafayette, IN 47907 USA
[3] Arnett Clin, Lafayette, IN USA
[4] St Elizabeth Hosp, Lafayette, IN USA
[5] Home Hosp, Lafayette, IN USA
关键词
adsorption; endotoxin; cytokines; sepsis; pheresis; clearance;
D O I
10.1046/j.1525-1594.1999.06232.x
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The BioLogic-DTPF System (DTPF) combines the Biologic-DT hemodiabsorption system (DT) in series with the Biologic PF push-pull pheresis system (PF) in which PF membranes separate plasma for direct contact between plasma proteins and the sorbents. Preliminary studies conducted in bovine serum albumin (BSA) solution and in bovine:plasma allowed charcoal and silica to be evaluated as adsorbents for the PF module. Equilibrium binding experiments in BSA showed a high capacity of cytokine (IL-1 beta, TNF alpha) binding by powdered charcoal, 70-90 ng/g. Kinetic binding studies in bovine plasma revealed relatively quick adsorption of IL-1 beta and IL-6 by charcoal with the capacity range of 1.2-2.0 ng/g for tested cytokines (IL-1 beta and TNF alpha). Further laboratory studies with plasma have shown that powdered silica has an even greater binding capacity, up to 13 ng/g for TNF alpha depending upon particle size, and more rapid binding for all tested cytokines than powdered charcoal. Cholestyramine is a more efficient sorbent for removal of endotoxin than either charcoal or silica. In vitro tests using whole blood have demonstrated that the DTPF, with powdered charcoal as the sorbent, clears cytokines (TNF alpha, IL-1 beta, and IL-6) at 12.6-23.4 ml/min, bilirubin at 17.8-34.7 ml/min? and creatinine at 53.6-82.6 ml/min. The removal of some cytokines during the first clinical trial is also discussed.
引用
收藏
页码:310 / 318
页数:9
相关论文
共 41 条
[1]  
Ash S R, 1994, ASAIO J, V40, P80
[2]  
ASH SR, 1992, INT J ARTIF ORGANS, V15, P151
[3]   HEMODIABSORPTION IN TREATMENT OF ACUTE HEPATIC-FAILURE AND CHRONIC CIRRHOSIS WITH ASCITES [J].
ASH, SR .
ARTIFICIAL ORGANS, 1994, 18 (05) :355-362
[4]   Push-pull sorbent based pheresis for treatment of acute hepatic failure - The biologic-detoxifier plasma filter system [J].
Ash, SR ;
Blake, DE ;
Carr, DJ ;
Harker, KD .
ASAIO JOURNAL, 1998, 44 (03) :129-139
[5]   INTERLEUKIN-6 AND INTERLEUKIN-8 EXTRACTION DURING CONTINUOUS VENOVENOUS HEMODIAFILTRATION IN SEPTIC ACUTE-RENAL-FAILURE [J].
BELLOMO, R ;
TIPPING, P ;
BOYCE, N .
RENAL FAILURE, 1995, 17 (04) :457-466
[6]   A 2ND LARGE CONTROLLED CLINICAL-STUDY OF E5, A MONOCLONAL-ANTIBODY TO ENDOTOXIN - RESULTS OF A PROSPECTIVE, MULTICENTER, RANDOMIZED, CONTROLLED TRIAL [J].
BONE, RC ;
BALK, RA ;
FEIN, AM ;
PERL, TM ;
WENZEL, RP ;
REINES, HD ;
QUENZER, RW ;
IBERTI, TJ ;
MACINTYRE, N ;
SCHEIN, RMH ;
TRENHOLME, G ;
NIEDERMAN, M ;
CHALFIN, D ;
ABALOS, A ;
OROPELLO, J ;
EMPSON, P ;
CAMINITII, S ;
GREENMAN, R ;
BOOTH, F ;
PLOUFFE, J ;
RUSSELL, J ;
GIANAKOPOULOS, G ;
IANNINI, P ;
HINDES, R ;
COBLENS, K ;
KOHLER, R ;
MARTIN, M ;
BERNARD, G ;
EDWARDS, J ;
CRISLIP, M ;
FILLER, S ;
NASRAWAY, SA ;
SIGEL, PK ;
SOTTILE, FD ;
MARTIN, DH ;
DEBOISBLANC, BP ;
CHANDRASEKAR, PH ;
BROUGHTON, WA ;
MIDDLETON, RM ;
SEIBERT, AF ;
EMMANUEL, G ;
LIE, TH ;
ANDERSON, CLV ;
PANKEY, GA ;
ANDERSON, P ;
OLSEN, K ;
SANPEDRO, GS ;
GRAHAM, D ;
GROSSMAN, J ;
WELS, PB .
CRITICAL CARE MEDICINE, 1995, 23 (06) :994-1006
[7]   Why sepsis trials fail [J].
Bone, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (07) :565-566
[9]   Sir Isaac Newton, sepsis, SIRS, and CARS [J].
Bone, RC .
CRITICAL CARE MEDICINE, 1996, 24 (07) :1125-1128
[10]   Efficacy of convective removal of plasma mediators of endotoxic shock by continuous veno-venous hemofiltration [J].
Bottoms, G ;
Fessler, J ;
Murphey, E ;
Johnson, M ;
Latshaw, H ;
Mueller, B ;
Clark, W ;
Macias, W .
SHOCK, 1996, 5 (02) :149-154